Overview

Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back Pain

Status:
Unknown status

Trial end date:
2019-10-01

Target enrollment:

Participant gender:

Summary

This study tests the hypothesis that radial extracorporeal shock wave therapy (rESWT) in combination with the non-steroidal anti-inflammatory drug Celecoxib and the antispasmodic drug Eperisone (hereafter, "C-E drug therapy") is statistically significantly more effective than either rESWT or C-E drug therapy alone in the treatment of chronic non-specific low back pain.

Phase:

N/A

Details

Lead Sponsor:

First Affiliated Hospital of Zhejiang University

Collaborator:

Ludwig-Maximilians - University of Munich

Treatments:

Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Celecoxib
Eperisone
Parasympatholytics